Keep the small acute study in context
A randomized, placebo-controlled crossover study enrolled 20 healthy young adults and compared single doses of ginkgo, ginseng, a combination product and placebo. It reported improvements on some cognitive tasks over the testing day. [1]
This is primary trial abstract evidence for specific preparations and acute outcomes. It does not establish dementia prevention, lasting benefit or safety for other populations. [1]
Review the full combination and medication list
NCCIH flags medicine interactions for both herbs. Ginkgo may increase bleeding risk with anticoagulants; Asian ginseng may affect blood sugar and interfere with clotting. [2][3]
A pharmacist or clinician should assess the exact products and medicines before combination use. A tested commercial mixture is not evidence that independently chosen products recreate its exposure. [2][3]
Do not generalize from one study day
Imagine a person plans to combine two capsules daily for months. A single-dose study in 20 healthy volunteers cannot settle that long-term safety question.
| Detail | Interpretation |
|---|---|
| Acute trial | One-day cognitive outcomes |
| Exact extracts | Part of the intervention |
| Long-term combination safety | Separate assessment |
Sources for this article
- Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults - PubMed
Source consulted: 2026-09-18. This is a reference resource, not a claim that we conducted the studies or tested a product. - Ginkgo: Usefulness and Safety | NCCIH
Source consulted: 2026-09-18. This is a reference resource, not a claim that we conducted the studies or tested a product. - Asian Ginseng: Usefulness and Safety | NCCIH
Source consulted: 2026-09-18. This is a reference resource, not a claim that we conducted the studies or tested a product.